Clinical impact of left ventricular hypertrophy and implications for regression.
about
Diabetic cardiomyopathy: bench to bedsideA follow-up study for left ventricular mass on chromosome 12p11 identifies potential candidate genesBilirubin Level is Associated with Left Ventricular Hypertrophy Independent of Blood Pressure in Previously Untreated Hypertensive PatientsT-cadherin is critical for adiponectin-mediated cardioprotection in mice.Extracellular signal-regulated kinases 1 and 2 regulate the balance between eccentric and concentric cardiac growthThree 4-letter words of hypertension-related cardiac hypertrophy: TRPC, mTOR, and HDAC.Heart disease is still a primary emphasis.βIIPKC and εPKC isozymes as potential pharmacological targets in cardiac hypertrophy and heart failureLeft ventricular mass and the risk of sudden cardiac death: a population-based studyComparison of radiological findings of chest x-ray with echocardiography in determination of the heart size.Left atrial volume index predictive of mortality independent of left ventricular geometry in a large clinical cohort with preserved ejection fraction.Inhibition of hypertrophy is a good therapeutic strategy in ventricular pressure overload.Biomarkers of inflammation and hemostasis associated with left ventricular mass: The Multiethnic Study of Atherosclerosis (MESA)Blood pressure, left ventricular geometry, and systolic function in children exposed to inorganic arsenic.High-mobility group box 1 induces calcineurin-mediated cell hypertrophy in neonatal rat ventricular myocytesCardioprotective actions of cyclic GMP: lessons from genetic animal models.Effects of muscular strength on cardiovascular risk factors and prognosisAssociation of ACE gene D polymorphism with left ventricular hypertrophy in patients with diastolic heart failure: a case-control study.Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.Clinical Diagnosis of Electrical Versus Anatomic Left Ventricular Hypertrophy: Prognostic and Therapeutic ImplicationsCardiac involvement in hereditary ataxiasChildhood ataxia: clinical features, pathogenesis, key unanswered questions, and future directions.Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitorsNADPH oxidase and cardiac failure.Regulation of myocardial growth and death by NADPH oxidase.Target of rapamycin (TOR)-based therapy for cardiomyopathy: evidence from zebrafish and human studies.Left-ventricular geometry and risk of sudden cardiac arrest in patients with preserved or moderately reduced left-ventricular ejection fraction.Cardiac Hypertrophy: An Introduction to Molecular and Cellular Basis.Imaging of Left Ventricular Hypertrophy: a Practical Utility for Differential Diagnosis and Assessment of Disease Severity.A combination of isolated phytochemicals and botanical extracts lowers diastolic blood pressure in a randomized controlled trial of hypertensive subjects.Does dapagliflozin regress left ventricular hypertrophy in patients with type 2 diabetes? A prospective, double-blind, randomised, placebo-controlled study.The association of sleep disordered breathing with left ventricular remodeling in CAD patients: a cross-sectional study.The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins.Detection of left ventricular hypertrophy in rats administered a peroxisome proliferator-activated receptor alpha/gamma dual agonist using natriuretic peptides and imaging.1,25-Dihydroxy vitamin D and coronary microvascular function.Association of Left Ventricular Geometry With Left Atrial Enlargement in Patients With Preserved Ejection Fraction.The effect of resveratrol on angiotensin II levels and the rate of transcription of its receptors in the rat cardiac hypertrophy model.Knockout of the Prostaglandin E2 Receptor Subtype 3 Promotes Eccentric Cardiac Hypertrophy and Fibrosis in Mice.Short-Term Treatment with Esmolol Reverses Left Ventricular Hypertrophy in Adult Spontaneously Hypertensive Rats via Inhibition of Akt/NF-κB and NFATc4.
P2860
Q26997062-33E93416-6B72-4D49-BA66-3975E486DC5DQ33972111-B29808BF-C0EA-437A-B72B-BFC49A9169CEQ34269653-BED70164-8FE0-4AF1-9133-A6599AA7FA34Q34360180-99A9093B-100C-46FA-AC75-22133034861AQ34544759-8F3CE09E-8C52-4023-8326-EECE93C35724Q34969926-F11B92EC-60CD-4699-9CE7-366001F0F3A9Q34986424-9EAFA02C-F4F2-4514-9A7C-287105EDDF7EQ35103455-94D1DDCC-BC5D-4101-8BB4-C909E80D7C30Q35115043-2C4A2DA9-224D-4E48-B510-707DCE7CA1FCQ35124089-CC6A5348-BB92-47BA-92F7-83D88B14C28DQ35136069-1CC9F092-8100-4A17-A8A9-43B8058A0BFEQ35534909-23D6079C-D46C-494F-9289-206B31E7E029Q35625858-89985B7C-0251-4E4D-A41C-28173F47BDA4Q35683192-DEC29AA1-4A81-4E70-B68A-FC938BD72DE3Q36072183-99F3B5C1-8670-4CEC-A481-BE1DFD07F8F7Q36164755-DF96CA5D-1962-4AB3-AA5E-5CF55A9537BCQ36392727-BBF8EC17-D700-4D9E-9773-82C56E5A2309Q36602874-7513E1D0-998A-40E7-B912-1814FFFF8CFEQ36714104-20E5B5FC-2E8C-47A2-A724-415A95A21540Q36729018-0375F892-304E-44EA-80CD-25DBA525A4D8Q36908105-76489BA8-E880-46B3-A558-C6262F155B6FQ36964084-FDB73BB2-07ED-43EA-8DEB-B711B77C289DQ37510643-6F4A99F0-C9FC-4062-A4E1-5595C1B28618Q37766127-A28F9467-37A9-410D-B79E-ECAF7E8A7040Q37826870-9DFC843A-FCEF-4479-92DF-9984BD53DE99Q38030250-51BC9957-9362-49BB-BF89-E556E0443F5CQ38379989-8BE0C043-FE6D-47BA-87C3-B9096A0FA344Q38906321-12CBBFD0-F0EF-4CF3-841B-36C40525A4C1Q39390119-E5B9EF68-0CA7-465C-929E-E3B67F7B8C14Q40852238-110E49D7-21A1-46EA-B402-9D641C92D1F3Q41507487-03135ED4-21C6-4E61-BC3F-B9CBB5FB955CQ41704741-790811C7-7C11-447E-A596-BA7BAC7AF329Q41991038-6350A0C4-9EF4-45BB-99DF-4036B44AE099Q43203756-43CE3F1C-E583-45D1-9EFF-0DB6F0F0E74EQ46641285-79B4CA0C-9F80-4EC3-9E0E-88681FF2DE26Q51479247-E47D2609-2FC9-407B-8340-4E0ED8A2A134Q51691944-8F742A69-6971-4F91-9CE5-EB8AF2A3C448Q54199502-78C52DBE-5C05-4D74-8400-968677E09B73Q54944403-F1F9482D-FB42-4536-AE81-63678F859AA0
P2860
Clinical impact of left ventricular hypertrophy and implications for regression.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical impact of left ventricular hypertrophy and implications for regression.
@en
Clinical impact of left ventricular hypertrophy and implications for regression.
@nl
type
label
Clinical impact of left ventricular hypertrophy and implications for regression.
@en
Clinical impact of left ventricular hypertrophy and implications for regression.
@nl
prefLabel
Clinical impact of left ventricular hypertrophy and implications for regression.
@en
Clinical impact of left ventricular hypertrophy and implications for regression.
@nl
P2093
P1476
Clinical impact of left ventricular hypertrophy and implications for regression.
@en
P2093
Anil Verma
Carl J Lavie
Dharmendrakumar A Patel
Hector O Ventura
Richard V Milani
Surya M Artham
P304
P356
10.1016/J.PCAD.2009.05.002
P577
2009-09-01T00:00:00Z